Cite

HARVARD Citation

    Nickolaus, P. et al. (2020). Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis. ERJ open research. 6 (4), p. . [Online]. 
  
Back to record